AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 10379016 — intervention group
Group type: EXPERIMENTAL
Intervention: Soft margarine diet (7.4 g trans fatty acid per 100 g fat)
Number of subjects: 36
Study 10379016 — intervention group
Group type: EXPERIMENTAL
Intervention: Shortening diet (9.9 g trans fatty acid per 100 g fat)
Number of subjects: 36
Study 10379016 — intervention group
Group type: EXPERIMENTAL
Intervention: Stick margarine diet (20.1 g trans fatty acid per 100 g fat)
Number of subjects: 36
Study 7735445 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefixime
Number of subjects: 57
Study 7735445 — intervention group
Group type: COMPARATOR
Intervention: Amoxicillin-clavulanate
Number of subjects: 57
Study 2282972 — intervention group
Group type: EXPERIMENTAL
Intervention: Sultamicillin (50 mg/kg.day or 500 mg/day)
Number of subjects: 86
Study 2282972 — intervention group
Group type: COMPARATOR
Intervention: Amoxycillin (40 mg/kg.day or 250 mg/day)
Number of subjects: 86
Study 6815695 — intervention group
Group type: EXPERIMENTAL
Intervention: IV L-tryptophan (TRP)
Number of subjects: 10
Study 31551370 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG and oral polio vaccine (OPV) administered at a single home visit
Number of subjects: 0
Study 31551370 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving information about vaccination opportunities
Number of subjects: 0
Study 29282085 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega3Q10
Number of subjects: 97
Study 29282085 — intervention group
Group type: COMPARATOR
Intervention: Soybean oil
Number of subjects: 97
Study 25478971 — intervention group
Group type: EXPERIMENTAL
Intervention: New sparse and incomplete factorial matrices for screening membrane protein 2D crystallization
Number of subjects: 16
Study 24423343 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 month weight loss program
Number of subjects: 17
Study 24423343 — intervention group
Group type: COMPARATOR
Intervention: Normal-weight counterparts
Number of subjects: 17
Study 22154318 — intervention group
Group type: EXPERIMENTAL
Intervention: In-treatment heart rate (HR)
Number of subjects: 9024
Study 22154318 — intervention group
Group type: EXPERIMENTAL
Intervention: In-treatment HR of ≥84 beats/min
Number of subjects: 9024
Study 22154318 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline HR as a continuous variable
Number of subjects: 9024
Study 22154318 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline HR of ≥84 beats/min
Number of subjects: 9024
Study 19670055 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive therapy plus risperidone (CogTher + Risp)
Number of subjects: 193
Study 19670055 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive therapy plus placebo (CogTher + Placebo)
Number of subjects: 193
Study 19670055 — intervention group
Group type: EXPERIMENTAL
Intervention: Supportive counselling plus placebo (Supp + Placebo)
Number of subjects: 193
Study 19670055 — intervention group
Group type: COMPARATOR
Intervention: Monitoring (no randomization)
Number of subjects: 193
Study 17138722 — intervention group
Group type: EXPERIMENTAL
Intervention: ID fat infusion with orlistat (120 mg)
Number of subjects: 36
Study 17138722 — intervention group
Group type: EXPERIMENTAL
Intervention: ID long-chain fatty acids (LCF)
Number of subjects: 36
Study 17138722 — intervention group
Group type: COMPARATOR
Intervention: ID medium-chain fatty acids (MCF)
Number of subjects: 36
Study 17138722 — intervention group
Group type: EXPERIMENTAL
Intervention: ID LCF with dexloxiglumide (Dexlox)
Number of subjects: 36
Study 17138722 — intervention group
Group type: EXPERIMENTAL
Intervention: ID fat or LCF
Number of subjects: 36
Study 17138722 — intervention group
Group type: COMPARATOR
Intervention: ID MCF
Number of subjects: 36
Study 15200654 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1 mg x kg(‐1) morphine hydrochloride (M)
Number of subjects: 60
Study 15200654 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5 mg x kg(‐1) tramadol hydrochloride (T)
Number of subjects: 60
Study 15200654 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg.kg(‐1) ketamine hydrochloride (K)
Number of subjects: 60
Study 15200654 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (S)
Number of subjects: 60
Study 12026029 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc supplementation or introduction of animal products as complementary foods
Number of subjects: 0
Study 12026029 — intervention group
Group type: COMPARATOR
Intervention: Human milk
Number of subjects: 0
Study 12026029 — intervention group
Group type: COMPARATOR
Intervention: Traditional early complementary foods (cereals, fruits, vegetables)
Number of subjects: 0
Study 10063567 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-year treatment with tamoxifen
Number of subjects: 341
Study 10063567 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic therapy added to local treatment of isolated locoregional recurrence
Number of subjects: 341
Study 7970004 — intervention group
Group type: EXPERIMENTAL
Intervention: Lamotrigine (200 to 500 mg daily, with higher dosages up to 700 mg in extension studies)
Number of subjects: 0
Study 7970004 — intervention group
Group type: EXPERIMENTAL
Intervention: Lamotrigine
Number of subjects: 0
Study 2659718 — intervention group
Group type: EXPERIMENTAL
Intervention: Special premature formula
Number of subjects: 25
Study 2659718 — intervention group
Group type: COMPARATOR
Intervention: Standard formula
Number of subjects: 25
Study 4947832 — intervention group
Group type: EXPERIMENTAL
Intervention: Aluminium-phosphate-adsorbed tetanus toxoid (1-3 injections of 1 ml)
Number of subjects: 1618
Study 4947832 — intervention group
Group type: COMPARATOR
Intervention: Placebo (influenza vaccine)
Number of subjects: 1618
Study 29145711 — intervention group
Group type: EXPERIMENTAL
Intervention: Prehospital antibiotic administration by paramedics
Number of subjects: 0
Study 29145711 — intervention group
Group type: COMPARATOR
Intervention: Delayed antibiotic therapy
Number of subjects: 0
Study 27149935 — intervention group
Group type: EXPERIMENTAL
Intervention: L-DOPA, specific dosage and duration not mentioned
Number of subjects: 0
Study 27149935 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 24637869 — intervention group
Group type: EXPERIMENTAL
Intervention: Gene expression profiling score variability
Number of subjects: 0
Study 24637869 — intervention group
Group type: EXPERIMENTAL
Intervention: Ordinal gene expression profiling scores
Number of subjects: 0
Study 24637869 — intervention group
Group type: EXPERIMENTAL
Intervention: Threshold gene expression profiling scores
Number of subjects: 0
Study 22185955 — intervention group
Group type: EXPERIMENTAL
Intervention: Chiropractic treatment (spinal manipulation) for 4 weeks
Number of subjects: 115
Study 22185955 — intervention group
Group type: COMPARATOR
Intervention: Self-management (minimal intervention) for 4 weeks
Number of subjects: 115
Study 20610576 — intervention group
Group type: EXPERIMENTAL
Intervention: Evaluation to Sign Consent form
Number of subjects: 100
Study 19100116 — intervention group
Group type: EXPERIMENTAL
Intervention: Pacing at right ventricular outflow tract (uncommon pacing group)
Number of subjects: 40
Study 19100116 — intervention group
Group type: COMPARATOR
Intervention: Pacing at ventricular cardiac apex (common pacing group)
Number of subjects: 40
Study 16896737 — intervention group
Group type: EXPERIMENTAL
Intervention: Fan airflow (FAN) during exercise
Number of subjects: 10
Study 16896737 — intervention group
Group type: COMPARATOR
Intervention: No cooling (NC) during exercise
Number of subjects: 10
Study 12787156 — intervention group
Group type: EXPERIMENTAL
Intervention: Signposts intervention system (group support, telephone support, self‐directed modes)
Number of subjects: 115
Study 12787156 — intervention group
Group type: EXPERIMENTAL
Intervention: Self‐directed mode of Signposts intervention
Number of subjects: 115
Study 10827386 — intervention group
Group type: EXPERIMENTAL
Intervention: Rescue percutaneous transluminal coronary angioplasty (PTCA) after failed fibrinolysis (TIMI 0 to 1 flow)
Number of subjects: 2433
Study 10827386 — intervention group
Group type: COMPARATOR
Intervention: Conservative therapy after fibrinolytic therapy
Number of subjects: 2433
Study 9395034 — intervention group
Group type: EXPERIMENTAL
Intervention: Study S7823
Number of subjects: 2083
Study 9395034 — intervention group
Group type: EXPERIMENTAL
Intervention: Study S8124
Number of subjects: 2083
Study 9395034 — intervention group
Group type: EXPERIMENTAL
Intervention: Study S8600
Number of subjects: 2083
Study 9395034 — intervention group
Group type: EXPERIMENTAL
Intervention: Study S7823 (age < 50 years)
Number of subjects: 2083
Study 9395034 — intervention group
Group type: EXPERIMENTAL
Intervention: Study S8124 (age < 50 years)
Number of subjects: 2083
Study 9395034 — intervention group
Group type: EXPERIMENTAL
Intervention: Study S8600 (age < 50 years)
Number of subjects: 2083
Study 9395034 — intervention group
Group type: EXPERIMENTAL
Intervention: Study S7823 (age < 50 years, complete remission)
Number of subjects: 2083
Study 9395034 — intervention group
Group type: EXPERIMENTAL
Intervention: Study S8124 (age < 50 years, complete remission)
Number of subjects: 2083
Study 9395034 — intervention group
Group type: EXPERIMENTAL
Intervention: Study S8600 (age < 50 years, standard dose cytarabine)
Number of subjects: 2083
Study 9395034 — intervention group
Group type: EXPERIMENTAL
Intervention: Study S8600 (age < 50 years, high dose cytarabine)
Number of subjects: 2083
Study 8383390 — intervention group
Group type: COMPARATOR
Intervention: Immune serum globulin (Ig) 0.06 ml/kg
Number of subjects: 49
Study 8383390 — intervention group
Group type: EXPERIMENTAL
Intervention: Inactivated hepatitis A virus vaccine (iHAV) single dose 25 ng
Number of subjects: 49
Study 8383390 — intervention group
Group type: EXPERIMENTAL
Intervention: Inactivated hepatitis A virus vaccine (iHAV) booster dose
Number of subjects: 49
Study 8383390 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study 3769702 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine 200 mg after each meal and at bedtime (200 mg qid)
Number of subjects: 5
Study 3769702 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine 400 mg after breakfast and at bedtime (400 mg bid)
Number of subjects: 5
Study 3769702 — intervention group
Group type: COMPARATOR
Intervention: Placebo tablets (control)
Number of subjects: 5
Study 3052675 — intervention group
Group type: EXPERIMENTAL
Intervention: EMLA cream
Number of subjects: 80
Study 3052675 — intervention group
Group type: COMPARATOR
Intervention: Infiltration of lignocaine solution
Number of subjects: 80
Study 31441233 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitting with 3-minute bouts of simple resistance activities (SRAs) every 30 minutes
Number of subjects: 19
Study 31441233 — intervention group
Group type: COMPARATOR
Intervention: Uninterrupted sitting
Number of subjects: 19
Study 28342647 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 Gy (EQD2Gy) to the elective lymph node regions
Number of subjects: 233
Study 24725373 — intervention group
Group type: EXPERIMENTAL
Intervention: Histamine provocation
Number of subjects: 40
Study 24725373 — intervention group
Group type: EXPERIMENTAL
Intervention: Bronchodilator use (salbutamol)
Number of subjects: 40
Study 24725373 — intervention group
Group type: EXPERIMENTAL
Intervention: Capnovolumetry
Number of subjects: 40
Study 23565002 — intervention group
Group type: EXPERIMENTAL
Intervention: Earplugs
Number of subjects: 400
Study 23565002 — intervention group
Group type: COMPARATOR
Intervention: No earplugs (Control)
Number of subjects: 400
Study 21798535 — intervention group
Group type: EXPERIMENTAL
Intervention: Breathable panty liners (BPLs) worn for 10‐12 hours each day for 75 consecutive days
Number of subjects: 107
Study 19553300 — intervention group
Group type: EXPERIMENTAL
Intervention: Exclusive breastfeeding for 4 months followed by rapid weaning to replacement foods
Number of subjects: 593
Study 19553300 — intervention group
Group type: COMPARATOR
Intervention: Exclusive breastfeeding for 6 months followed by introduction of complementary foods and continued breastfeeding
Number of subjects: 593
Study 19553300 — intervention group
Group type: EXPERIMENTAL
Intervention: Not breastfeeding
Number of subjects: 593
Study 19553300 — intervention group
Group type: EXPERIMENTAL
Intervention: Breastfeeding practice
Number of subjects: 593
Study 16428253 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 month collaborative care intervention (IMPACT)
Number of subjects: 1801
Study 16428253 — intervention group
Group type: COMPARATOR
Intervention: usual care for depression
Number of subjects: 1801
Study 12440551 — intervention group
Group type: EXPERIMENTAL
Intervention: Ionized bracelet
Number of subjects: 610
Study 12440551 — intervention group
Group type: COMPARATOR
Intervention: Placebo bracelet
Number of subjects: 610
Study 10523367 — intervention group
Group type: EXPERIMENTAL
Intervention: 24-hour ambulatory blood pressure measurement
Number of subjects: 2650
Study 10523367 — intervention group
Group type: EXPERIMENTAL
Intervention: Daytime ambulatory blood pressure measurement
Number of subjects: 2650
Study 10523367 — intervention group
Group type: COMPARATOR
Intervention: Clinic blood pressure measurement by physician
Number of subjects: 2650
Study 10523367 — intervention group
Group type: COMPARATOR
Intervention: Clinic blood pressure measurement by nurse
Number of subjects: 2650
Study 10523367 — intervention group
Group type: COMPARATOR
Intervention: Home blood pressure measurement by nurse
Number of subjects: 2650
Study 10523367 — intervention group
Group type: COMPARATOR
Intervention: Self-measured blood pressure
Number of subjects: 2650
Study 10523367 — intervention group
Group type: COMPARATOR
Intervention: Clinic blood pressure measurement by physician (subgroup with self-measurement)
Number of subjects: 2650
Study 10523367 — intervention group
Group type: COMPARATOR
Intervention: Clinic blood pressure measurement by nurse (subgroup with self-measurement)
Number of subjects: 2650
Study 10523367 — intervention group
Group type: COMPARATOR
Intervention: Home blood pressure measurement by nurse (subgroup with self-measurement)
Number of subjects: 2650
Study 10523367 — intervention group
Group type: COMPARATOR
Intervention: Daytime ambulatory blood pressure measurement (subgroup with self-measurement)
Number of subjects: 2650
Study 10523367 — intervention group
Group type: COMPARATOR
Intervention: 24-hour ambulatory blood pressure measurement (subgroup with self-measurement)
Number of subjects: 2650
Study 7722855 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulating borderline personality disorder on the MMPI-2
Number of subjects: 0
Study 7722855 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulating major depression on the MMPI-2
Number of subjects: 0
Study 7722855 — intervention group
Group type: COMPARATOR
Intervention: Clinical comparison group diagnosed with borderline personality disorder
Number of subjects: 0
Study 7722855 — intervention group
Group type: COMPARATOR
Intervention: Honest responses to the MMPI-2
Number of subjects: 0
Study 7722855 — intervention group
Group type: EXPERIMENTAL
Intervention: F scale analysis
Number of subjects: 0
Study 7722855 — intervention group
Group type: EXPERIMENTAL
Intervention: Borderline Personality Disorder Scale (BPDsc) analysis
Number of subjects: 0
Study 1817055 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial periodontal therapy consisting of a single subgingival root debridement procedure followed by repeated monthly subgingival irrigations over a period of 6 months
Number of subjects: 23
Study 1817055 — intervention group
Group type: COMPARATOR
Intervention: Single root debridement procedure
Number of subjects: 23
Study 7018187 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-selective beta-blockade
Number of subjects: 13
Study 7018187 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardioselective beta-blockade
Number of subjects: 13
Study 7018187 — intervention group
Group type: COMPARATOR
Intervention: Cold pressor test
Number of subjects: 13
Study 7018187 — intervention group
Group type: COMPARATOR
Intervention: Mental arithmetics
Number of subjects: 13
Study 31658113 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg nicotine lozenge
Number of subjects: 723
Study 31658113 — intervention group
Group type: COMPARATOR
Intervention: Placebo lozenge
Number of subjects: 723
Study 31658113 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 mg nicotine lozenge
Number of subjects: 723
Study 30442692 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-layered susceptibility vessel sign and high overestimation ratio on pretreatment brain T2* sequences
Number of subjects: 260
Study 26198808 — intervention group
Group type: EXPERIMENTAL
Intervention: IAI 2 mg every 4 weeks (2q4)
Number of subjects: 872
Study 26198808 — intervention group
Group type: EXPERIMENTAL
Intervention: IAI 2 mg every 8 weeks after 5 monthly doses (2q8)
Number of subjects: 872
Study 26198808 — intervention group
Group type: COMPARATOR
Intervention: Laser control
Number of subjects: 872
Study 23750019 — intervention group
Group type: EXPERIMENTAL
Intervention: Group Lifestyle Modification Program (Group LMP)
Number of subjects: 169
Study 23750019 — intervention group
Group type: COMPARATOR
Intervention: Self-Guided Lifestyle Modification Program (Self-Guided LMP)
Number of subjects: 169
Study 22315807 — intervention group
Group type: EXPERIMENTAL
Intervention: Electro acupuncture therapy (10 sittings on alternate days at GB and UB points)
Number of subjects: 60
Study 22315807 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional drug therapy (oral Valdecoxib) with supervised physiotherapy
Number of subjects: 60
Study 22315807 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy volunteers)
Number of subjects: 60
Study 18445172 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous subcutaneous infusion of insulin aspart
Number of subjects: 21
Study 18445172 — intervention group
Group type: COMPARATOR
Intervention: Insulin injection of insulin glargine
Number of subjects: 21
Study 16941338 — intervention group
Group type: EXPERIMENTAL
Intervention: Highly active antiretroviral therapy (HAART) for 24 weeks
Number of subjects: 20
Study 16941338 — intervention group
Group type: COMPARATOR
Intervention: Untreated subjects
Number of subjects: 20
Study 14622632 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualised fluid prescription (30 ml/kg body weight/24 h, max 35 ml/kg body weight/24 h)
Number of subjects: 0
Study 14622632 — intervention group
Group type: COMPARATOR
Intervention: Standard fluid intake (maximum 1.5 l)
Number of subjects: 0
Study 11198484 — intervention group
Group type: EXPERIMENTAL
Intervention: Noninvasive measurement of beat-to-beat blood pressure during the Valsalva maneuver
Number of subjects: 70
Study 11198484 — intervention group
Group type: EXPERIMENTAL
Intervention: Invasive measurement of beat-to-beat blood pressure
Number of subjects: 70
Study 8625244 — intervention group
Group type: EXPERIMENTAL
Intervention: M-VEC (methotrexate, vinblastine, epirubicin, and cisplatin)
Number of subjects: 57
Study 8625244 — intervention group
Group type: COMPARATOR
Intervention: M-VECa (methotrexate, vinblastine, epirubicin, and carboplatin)
Number of subjects: 57
Study 8625244 — intervention group
Group type: EXPERIMENTAL
Intervention: M-VEC
Number of subjects: 57
Study 8625244 — intervention group
Group type: COMPARATOR
Intervention: M-VECa
Number of subjects: 57
Study 10122538 — intervention group
Group type: EXPERIMENTAL
Intervention: Medicaid HMO
Number of subjects: 0
Study 10122538 — intervention group
Group type: COMPARATOR
Intervention: Fee-for-Service (FFS)
Number of subjects: 0
Study 6141182 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative practice
Number of subjects: 0
Study 6141182 — intervention group
Group type: EXPERIMENTAL
Intervention: Desensitization
Number of subjects: 0
Study 6141182 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxation only
Number of subjects: 0
Study 6141182 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control
Number of subjects: 0
Study 31023762 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma Lp(a) levels measured at baseline
Number of subjects: 9698
Study 29602346 — intervention group
Group type: EXPERIMENTAL
Intervention: Grafted facemask therapy
Number of subjects: 61
Study 29602346 — intervention group
Group type: EXPERIMENTAL
Intervention: Ungrafted facemask therapy
Number of subjects: 61
Study 29602346 — intervention group
Group type: EXPERIMENTAL
Intervention: Facemask therapy (grafted and ungrafted)
Number of subjects: 61
Study 29602346 — intervention group
Group type: EXPERIMENTAL
Intervention: Grafted group
Number of subjects: 61
Study 29602346 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 61
Study 29602346 — intervention group
Group type: EXPERIMENTAL
Intervention: Ungrafted group
Number of subjects: 61
Study 27195774 — intervention group
Group type: EXPERIMENTAL
Intervention: Ferric carboxymaltose (FCM) with erythropoietin (EPO) - 1 g IV FCM plus 40,000 IU subcutaneous EPO
Number of subjects: 306
Study 27195774 — intervention group
Group type: EXPERIMENTAL
Intervention: Ferric carboxymaltose (FCM) without erythropoietin (EPO) - 1 g IV FCM plus subcutaneous placebo
Number of subjects: 306
Study 27195774 — intervention group
Group type: COMPARATOR
Intervention: Placebo - IV and subcutaneous placebo
Number of subjects: 306
Study 25493656 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-ICU hospitalized patients
Number of subjects: 11243
Study 25493656 — intervention group
Group type: EXPERIMENTAL
Intervention: ICU patients
Number of subjects: 11243
Study 25493656 — intervention group
Group type: COMPARATOR
Intervention: Not hospitalized (control group)
Number of subjects: 11243
Study 23077155 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral steroid for 10 days (group I)
Number of subjects: 60
Study 23077155 — intervention group
Group type: EXPERIMENTAL
Intervention: Intratympanic dexamethasone injection (ITDI) 4 times (group II)
Number of subjects: 60
Study 23077155 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of oral steroid and ITDI (group III)
Number of subjects: 60
Study 23077155 — intervention group
Group type: COMPARATOR
Intervention: Overall recovery rate across all groups
Number of subjects: 60
Study 19912211 — intervention group
Group type: EXPERIMENTAL
Intervention: Bipolar TURP (Surgmaster TURis, Olympus, Tokyo, Japan)
Number of subjects: 202
Study 19912211 — intervention group
Group type: COMPARATOR
Intervention: Monopolar TURP (24 F, Storz, Tübingen, Germany)
Number of subjects: 202
Study 17994222 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine prescription of daily CXRs
Number of subjects: 165
Study 17994222 — intervention group
Group type: COMPARATOR
Intervention: Restrictive prescription of clinically indicated CXRs
Number of subjects: 165
Study 17994222 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 165
Study 16906020 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyp3A5*3 homozygotes
Number of subjects: 44